Poland

Poland: an interesting Self-Medication and Pharma market next to Germany

Poland’s Self-Medication and Pharma market underwent changes in the past few years, putting them on the map of European markets full of opportunities.  

Pharmaceutical exports, especially to Western Europe, have been strong and on the rise, as local producers have increased their focus on more advanced-medicine markets in the last few years. Poland’s consumer healthcare and pharma market value reached USD 8,9 billion in 2021, ex-factory, and is expected to reach USD 18,42 billion by 2035, according to Chameleon Pharma Consulting Group forecasts.

Reforms over the last 10 years have led to a more mature and transparent environment in healthcare. Major changes were introduced in the pricing and reimbursement system, with the goal of increasing transparency, reducing drug spending, and providing higher access to innovations. 

Chameleon Pharma Consulting Group has devel­oped a sys­tem­atic part­ner search process that can iden­tify the most suit­able local part­ner for you in Poland in only 10-12 weeks. Simply contact us for more details!